Naphazoline
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162728This classification denotes an alpha-adrenergic agonist with the molecular formula C14H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) H231GF11BV, chemically known as 4,5-dihydro-2-(1-naphthylmethyl)imidazole but more generally known as naphazoline, which bears US NIH Compound Identifier 4436. European Medicines Agency schedules Naphazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09154MIG. The term NAPHAZOLINE is an International Non-Proprietary Name. World Health Organization schedules naphazoline in its Anatomical Therapeutic Chemical (ATC) Classification. NAPHAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule naphazoline under HS 29332990 and SITC 51573. As of Q4 2014, NAPHAZOLINE remains US FDA's Preferred Term for this commodity. Naphazoline bears US NLM identifiers UMLS ID C0027373 and NCI Concept Code C61856. SMILES: N1C(=NCC1)CC1C2C(CCC1)CCCC2.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.